IPO Date: Feb 10 to Feb 12 2025
Listing Date: Feb 17 2025
Biotech Park, Sector G Kursi Road Jankipuram
Lucknow
Uttar Pradesh
226021
8069366666
secretarial@chandan.co.in
www.chandandiagnostic.com
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Pursuant to Regulations 33 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Garodia Chemicals has informed that it enclosed a copy of the newspaper advertisement published in ‘Business Standard’ in English Language and ‘Mumbai Mitra’ in Marathi Language dated November 07, 2026, with respect to Un-Audited Financial Results for the Quarter and Half-year ended September 30, 2026, approved at the meeting of Board of Directors held on November 06, 2026.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30(6) and 46 (2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, BMW Industries has informed that the audio recording of the Investors’/Analyst Meet (Earnings Call) held on November 06, 2026 at 10:00 AM (IST) on the Unaudited Standalone and Consolidated Financial Results for the Second Quarter and Half-Year ended 30th September, 2026 is available on the Company's website at: https://www.bmwil.co.in/wpcontent/uploads/2026/11/audio-1800170970.m4a.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Shareholders’ approval dated September 29, 2026 and In-Principle approval letter No. LOD/PREF/RB/FIP/1044/2026-27 dated November 02, 2026 issued by the BSE and Letter Ref: NSE/LIST/57286 dated November 03, 2026 issued by the National Stock Exchange of India, Kiri Industries has informed that the Board of Directors of the Company at its meeting held on today, have approved the allotment of 60,82,600 warrants at an issue price of INR 475 (‘Warrants Issue Price’), aggregating up to INR 288,92,35,000, on a preferential basis by way of a private placement, to the promoters and members of the Promoter group. The Company has received Rs 123.50 per warrant i.e. 26.00% of the Warrants Issue price, aggregating to Rs. 75,12,01,100 as per the details enclosed.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Chandan Healthcare Ltd. IPO is ₹74.04 - 77.96 crore.
The Chandan Healthcare Ltd. IPO opens for subscription on 2025-02-10 and closes on 2025-02-12.
The price range of Chandan Healthcare Ltd. IPO is ₹151.00 to ₹159.00.
The lot size of Chandan Healthcare Ltd. IPO is 800 shares.
The registrar of Chandan Healthcare Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.